Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfredi Rizzo

Showing results (241-250 of 522) with videos related to

Pageof 53
Sort By:
Current Pharmaceutical Design|January 5, 2013
Combined dyslipidemia: should the focus be LDL cholesterol or atherogenic dyslipidemia?Manfredi Rizzo, Marcin Barylski, Ali A Rizvi, et al.
Archives of Dermatological Research|June 12, 2013
Rational for statin use in psoriatic patientsJerzy Mosiewicz, Aldona Pietrzak, Grażyna Chodorowska, et al.
Current Pharmaceutical Design|December 11, 2013
Incretin-based therapies, glucometabolic health and endovascular inflammationManfredi Rizzo, Dragana Nikolic, Maciej Banach, et al.
Current Pharmaceutical Biotechnology|April 12, 2014
Gestational diabetes and the metabolic syndrome: can obesity and small, dense low density lipoproteins be key mediators of this association?Ali A Rizvi, Silvia Cuadra, Dragana Nikolic, et al.
Metabolites|December 23, 2021
CRISPR Gene Editing in Lipid Disorders and Atherosclerosis: Mechanisms and OpportunitiesHarry E Walker, Manfredi Rizzo, Zlatko Fras, et al.
Frontiers in Endocrinology|March 17, 2023
The Na<sup>+</sup>/K<sup>+</sup>-ATPase: A potential therapeutic target in cardiometabolic diseasesMilan Obradovic, Emina Sudar-Milovanovic, Zoran Gluvic, et al.
Journal of Diabetes and Its Complications|October 4, 2024
The importance of arterial stiffness in pediatric patients with type 1 diabetes mellitus: What's new?Evangelos C Rizos, Evangelia E Ntzani, Imran Rashid Rangraze, et al.
Journal of Clinical Medicine|November 27, 2024
Glucometabolic Efficacy of the Empagliflozin/Metformin Combination in People with Type 1 Diabetes and Increased Cardiovascular Risk: A Sub-Analysis of a Pilot Randomized Controlled TrialMiodrag Janić, Andrej Janež, Mišo Šabović, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 26, 2021
Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical ReviewDjordje S Popovic, Nikolaos Papanas, Anca Pantea Stoian, et al.
Endocrine|November 11, 2021
Glucose transporter 4 mRNA expression in subcutaneous adipose tissue of women with PCOS remains unchanged despite metformin withdrawal: is there a cellular metabolic treatment legacy effect?Mojca Jensterle, Nika Aleksandra Kravos, Vita Dolžan, et al.
Pageof 53

Showing results (241-250 of 522) with videos related to

Sort By:
Pageof 53
Current Pharmaceutical Design|January 5, 2013
Combined dyslipidemia: should the focus be LDL cholesterol or atherogenic dyslipidemia?Manfredi Rizzo, Marcin Barylski, Ali A Rizvi, et al.
Archives of Dermatological Research|June 12, 2013
Rational for statin use in psoriatic patientsJerzy Mosiewicz, Aldona Pietrzak, Grażyna Chodorowska, et al.
Current Pharmaceutical Design|December 11, 2013
Incretin-based therapies, glucometabolic health and endovascular inflammationManfredi Rizzo, Dragana Nikolic, Maciej Banach, et al.
Current Pharmaceutical Biotechnology|April 12, 2014
Gestational diabetes and the metabolic syndrome: can obesity and small, dense low density lipoproteins be key mediators of this association?Ali A Rizvi, Silvia Cuadra, Dragana Nikolic, et al.
Metabolites|December 23, 2021
CRISPR Gene Editing in Lipid Disorders and Atherosclerosis: Mechanisms and OpportunitiesHarry E Walker, Manfredi Rizzo, Zlatko Fras, et al.
Frontiers in Endocrinology|March 17, 2023
The Na<sup>+</sup>/K<sup>+</sup>-ATPase: A potential therapeutic target in cardiometabolic diseasesMilan Obradovic, Emina Sudar-Milovanovic, Zoran Gluvic, et al.
Journal of Diabetes and Its Complications|October 4, 2024
The importance of arterial stiffness in pediatric patients with type 1 diabetes mellitus: What's new?Evangelos C Rizos, Evangelia E Ntzani, Imran Rashid Rangraze, et al.
Journal of Clinical Medicine|November 27, 2024
Glucometabolic Efficacy of the Empagliflozin/Metformin Combination in People with Type 1 Diabetes and Increased Cardiovascular Risk: A Sub-Analysis of a Pilot Randomized Controlled TrialMiodrag Janić, Andrej Janež, Mišo Šabović, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 26, 2021
Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical ReviewDjordje S Popovic, Nikolaos Papanas, Anca Pantea Stoian, et al.
Endocrine|November 11, 2021
Glucose transporter 4 mRNA expression in subcutaneous adipose tissue of women with PCOS remains unchanged despite metformin withdrawal: is there a cellular metabolic treatment legacy effect?Mojca Jensterle, Nika Aleksandra Kravos, Vita Dolžan, et al.
Pageof 53